SG11202108529WA - Biotechnological optimization of microorganisms for the 1,2-dehydrogenation of steroids - Google Patents

Biotechnological optimization of microorganisms for the 1,2-dehydrogenation of steroids

Info

Publication number
SG11202108529WA
SG11202108529WA SG11202108529WA SG11202108529WA SG11202108529WA SG 11202108529W A SG11202108529W A SG 11202108529WA SG 11202108529W A SG11202108529W A SG 11202108529WA SG 11202108529W A SG11202108529W A SG 11202108529WA SG 11202108529W A SG11202108529W A SG 11202108529WA
Authority
SG
Singapore
Prior art keywords
biotechnological
dehydrogenation
steroids
microorganisms
optimization
Prior art date
Application number
SG11202108529WA
Other languages
English (en)
Inventor
Claus Tobias Lattemann
Bernd Janocha
Hans-Falk Rasser
Sebastian Rissom
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of SG11202108529WA publication Critical patent/SG11202108529WA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • C12P33/02Dehydrogenating; Dehydroxylating
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/001Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/365Nocardia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/010533-Alpha (or 20-beta)-hydroxysteroid dehydrogenase (1.1.1.53)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y103/00Oxidoreductases acting on the CH-CH group of donors (1.3)
    • C12Y103/99Oxidoreductases acting on the CH-CH group of donors (1.3) with other acceptors (1.3.99)
    • C12Y103/990043-Oxosteroid 1-dehydrogenase (1.3.99.4)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
SG11202108529WA 2019-02-08 2020-02-07 Biotechnological optimization of microorganisms for the 1,2-dehydrogenation of steroids SG11202108529WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19305153 2019-02-08
PCT/EP2020/053167 WO2020161317A1 (en) 2019-02-08 2020-02-07 Biotechnological optimization of microorganisms for the 1,2-dehydrogenation of steroids

Publications (1)

Publication Number Publication Date
SG11202108529WA true SG11202108529WA (en) 2021-09-29

Family

ID=66554300

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202108529WA SG11202108529WA (en) 2019-02-08 2020-02-07 Biotechnological optimization of microorganisms for the 1,2-dehydrogenation of steroids

Country Status (13)

Country Link
US (1) US20220136029A1 (pt)
EP (1) EP3921414A1 (pt)
JP (1) JP2022519711A (pt)
KR (1) KR20210125490A (pt)
CN (1) CN113423827A (pt)
AU (1) AU2020219424A1 (pt)
BR (1) BR112021015481A2 (pt)
CA (1) CA3128954A1 (pt)
IL (1) IL285386A (pt)
MX (1) MX2021009515A (pt)
SG (1) SG11202108529WA (pt)
WO (1) WO2020161317A1 (pt)
ZA (1) ZA202105566B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2021009515A (es) * 2019-02-08 2021-10-26 Sanofi Sa Optimizacion biotecnologica de microorganismos para la 1,2-deshidrogenacion de esteroides.
CN118325997A (zh) * 2024-04-10 2024-07-12 湖南玉新药业有限公司 采用诺卡氏菌一步发酵生产泼尼松龙的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1703908A4 (en) * 2003-12-22 2009-07-08 Amgen Inc ARYLSULFONAMIDE COMPOUNDS AND RELATED APPLICATIONS
US20050239853A1 (en) * 2004-02-04 2005-10-27 Tjeerd Barf New compounds
US20070015236A1 (en) * 2005-04-05 2007-01-18 Albert Fliss Process of preparing prednisolone devoid of steroid-derived impurities using recombinant E. coli transformed with A delta¹-dehydrogenase gene
AU2013200516B2 (en) * 2006-07-12 2015-09-03 University Of Tennessee Research Foundation Substituted Acylanilides and Methods of Use Thereof
EP2511844B1 (en) * 2006-10-10 2015-08-12 XRpro Sciences, Inc. X-ray microscope
CN106754775B (zh) * 2016-12-23 2019-08-20 华东理工大学 一种羰基还原酶突变体及其基因与应用
WO2018204764A1 (en) * 2017-05-05 2018-11-08 Camp4 Therapeutics Corporation Identification and targeted modulation of gene signaling networks
CN113329754A (zh) * 2018-11-20 2021-08-31 麻雀制药股份有限公司 用于施用皮质类固醇的方法
MX2021009515A (es) * 2019-02-08 2021-10-26 Sanofi Sa Optimizacion biotecnologica de microorganismos para la 1,2-deshidrogenacion de esteroides.

Also Published As

Publication number Publication date
CA3128954A1 (en) 2020-08-13
KR20210125490A (ko) 2021-10-18
BR112021015481A2 (pt) 2021-12-07
JP2022519711A (ja) 2022-03-24
WO2020161317A1 (en) 2020-08-13
EP3921414A1 (en) 2021-12-15
ZA202105566B (en) 2024-05-30
TW202045720A (zh) 2020-12-16
MX2021009515A (es) 2021-10-26
IL285386A (en) 2021-09-30
US20220136029A1 (en) 2022-05-05
AU2020219424A1 (en) 2021-08-26
CN113423827A (zh) 2021-09-21

Similar Documents

Publication Publication Date Title
EP3587557A4 (en) LARVE DETENEBRIO ISOLATED MICRO-ORGANISM
EP4028269A4 (en) SUSPENSION SYSTEM
EP3705321B8 (en) Suspension system
EP3914463B8 (de) Feder-dämpfer-system
EP3674394A4 (en) PRIMARY CULTURE PROCESS
EP3815941A4 (en) SUSPENSION
IL285386A (en) Biotechnological optimization of microorganisms for 2,1-dehydrogenation of steroids
EP4079398A4 (en) FLOW REACTOR
EP3943775A4 (en) SUSPENSION DEVICE
EP3955069A4 (en) CONTROL DEVICE SYSTEM
EP4083560A4 (en) FLOW REACTOR
GB201913196D0 (en) Culture method
EP3730606A4 (en) NEW METHOD OF INDUCTION OF OSTEOGENIC DIFFERENTIATION
EP3670642A4 (en) MICRO-ORGANISM CULTURE SYSTEM
SG11202112732SA (en) Incubation system
EP3940476A4 (en) CONTROL SYSTEM
EP3681365A4 (en) LARGE-SCALE BIOREACTOR
EP3575419A4 (en) METHOD FOR OPERATING A CONVERTER SOF
EP4071294A4 (en) CORD WINDING IRON
EP4053514A4 (en) PLANT BIOSENSOR
EP3992001A4 (en) SUSPENSION DEVICE
EP3964900A4 (en) CONTROL UNIT
EP4051268A4 (en) D-AMPHETAMIN COMPOUNDS, COMPOSITIONS AND METHODS FOR THEIR PREPARATION AND USE
EP3951624A4 (en) CONTROL UNIT SYSTEM
GB201912021D0 (en) Methods, products & Uses relating thereto